跳到正文
原文
openFDA 器械召回·· 21 天前精选AI 评分40

美敦力 MiniMed Go App 1.2.1 版长效胰岛素剂量提醒失效被召回

Generic Name: MiniMed Go App Generic Name: MiniMed Go App Model/Catalog Number: MMT-8600 (iOS), MMT-8601 (Android) Software Version: Software version 1.2.1 Product Description: The MiniMed Go app for iOS or MiniMed Go app for Android is compatible with the following components: " Simplera sensor " Instinct sensor " InPen smart insulin pen " Apple Watch [Optional] Continuous glucose monitoring (CGM) is a technology that allows you to continuously view glucose values. The app uses an inserted Simplera sensor CGM or Instinct sensor CGM with Bluetooth¿ wireless technology that converts small amounts of glucose from the interstitial fluid under the skin into an electronic signal. The sensors use that signal to provide sensor glucose (SG) values to the MiniMed Go app on a compatible mobile device. The app also provides alerts based on your SG levels and contains a user interface for entering data such as insulin, meals, exercise, blood glucose (BG) values, and uploading information to the Ca

AI 导读

openFDA 器械召回信息显示,MiniMed Go App 1.2.1 版(iOS MMT-8600、Android MMT-8601)存在软件缺陷:此前在 1.2.0 及更早版本中已配置并启用长效剂量提醒的用户,升级后提醒功能失效。

推荐理由

召回说明披露了软件升级导致提醒失效的技术原因,以及漏服或重复注射可能引发的血糖风险。

来源:openFDA 器械召回 · api.fda.gov